Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 20, 2012BMC MedicineOpen Access

Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants

View Full Paper
Ask AI
Bookmark
Share

Authors

AAAli AlkhafajiLTLudovic TrinquartGBGabriel Baron

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Alkhafaji et al. (2012) studied this question.

synapsesocial.com/papers/6a20b335ac4c2e2edfeb8cb8https://doi.org/10.1186/1741-7015-10-142
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Evaluating novel agent effects in multiple‐treatments meta‐regression2010 · 113 citations
  2. 2Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses2003 · 949 citations
  3. 3Methodology in conducting a systematic review of systematic reviews of healthcare interventions2011 · 1,285 citations
  4. 4Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians2008 · 238 citations